Industry News (Clinical Trials)
Phase I AG1549 Clinical Trial Initiated To Treat HIV
Published in AIDS Weekly, June 14th, 1999
Immunity Care and Research, LLC is conducting this Phase I trial to evaluate the safety, tolerance, pharmacokinetics, and antiviral activity in 30 HIV patients.
This article was prepared by AIDS Weekly editors from staff and other reports. Copyright 1999, AIDS Weekly via NewsRx.com.
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1999-06-14)
More Articles from AIDS Weekly
- AIDS Therapies
New HIV NC Inhibitor Has Novel Mode of Action - AIDS Pathogenesis
AIDS TP Linked to SI HIV - Immune Restoration
AIDS-Ravaged Lymphoid Tissues Regenerate with HAART - Coinfection (HBV/HIV)
HBV Mutations Common in HIV+ Patients Treated with Lamivudine - Genotyping
Changes in Genotype Common in Hemophiliacs - AIDS Therapies
"Berlin Patient" Case Points To Promise of "New HAART" Regimens to Treat HIV - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
